- Trials with a EudraCT protocol (112)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
112 result(s) found for: Adrenal Function.
Displaying page 1 of 6.
EudraCT Number: 2021-002528-18 | Sponsor Protocol Number: RESCUE2131PE9 | Start Date*: 2022-02-22 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: RESCUE - Effect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency; A multicentre, randomised, double blinded, placebo-controlled clinical trial on health-re... | |||||||||||||
Medical condition: Glucocorticoid-induced adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-006121-65 | Sponsor Protocol Number: 65411807 | Start Date*: 2021-08-31 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: STUDY PROTOCOL: A multi-centre, randomized, double-blinded, placebo controlled 1-year study to compare the effect of hydrocortisone and palcebo in patients with partial adrenal insufficiency after ... | |||||||||||||
Medical condition: To investigate the effects of hydrocortisone replacement in participants with previous PMR and GCA, who are in GC-free remission and exhibit biochemical evidence of mild to moderate adrenal insuffi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001802-27 | Sponsor Protocol Number: F002MH0218_1 | Start Date*: 2019-04-16 | ||||||||||||||||||||||||||
Sponsor Name:University Hospital Wuerzburg | ||||||||||||||||||||||||||||
Full Title: A Multicenter, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Cabozantinib in Advanced (Unresectable or Metastatic) Adrenocortical Carcinoma. | ||||||||||||||||||||||||||||
Medical condition: Advanced (Unresectable or Metastatic) Adrenocortical Carcinoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003241-15 | Sponsor Protocol Number: SCH/12/043 | Start Date*: 2012-10-09 | ||||||||||||||||
Sponsor Name:Sheffield Children's NHS Foundation Trust | ||||||||||||||||||
Full Title: NeSST2: A multi-stage clinical study to develop a non-invasive Short Synacthen Test (SST) with nasally administered Synacthen and salivary cortisol. The validated non-invasive SST will be used to e... | ||||||||||||||||||
Medical condition: In stages 1+2 of the study healthy volunteers will be used to determine the bioequivalence of nasal Synacthen with 1 microgram of intravenous synacthen. Stage 3 will use healthy children to establi... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013355-29 | Sponsor Protocol Number: SCH/09/018 | Start Date*: 2010-07-02 | ||||||||||||||||
Sponsor Name:Sheffield Children's NHS Foundation Hospital | ||||||||||||||||||
Full Title: A multi-stage clinical study to develop a non-invasive Short Synacthen Test (SST) with nasally administered synacthen and salivary cortisol. The validated non-invasive SST will be used to establish... | ||||||||||||||||||
Medical condition: In stages 1+2 of the study healthy volunteers will be used to determine the bioequivalence of nasal synacthen with 1 microgram of intravenous synacthen. Stage 3 will use healthy children to establi... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012820-97 | Sponsor Protocol Number: OSI-906-301 | Start Date*: 2009-12-29 | |||||||||||
Sponsor Name:Astellas Pharma Global Development, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma | |||||||||||||
Medical condition: Adrenocortical Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) FR (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022677-34 | Sponsor Protocol Number: EMR200109-619 | Start Date*: 2011-09-07 | ||||||||||||||||
Sponsor Name:Dekan des Fachbereichs Humanmedizin | ||||||||||||||||||
Full Title: Influence of high dose vitamin D substitution on humoral immunity and lymphocyte function in patients with type 1 diabetes mellitus or Addison´s disease (ViDDA1) | ||||||||||||||||||
Medical condition: Type 1 diabetes mellitus or Addison´s disease (ViDDA1) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001682-33 | Sponsor Protocol Number: 6176/RADS2 | Start Date*: 2012-09-06 | |||||||||||||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison’s Disease | |||||||||||||||||||||||
Medical condition: Autoimmune Addison's disease: autoimmune primary adrenal insufficiency | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002632-99 | Sponsor Protocol Number: ONC-NET-01 | Start Date*: 2011-10-14 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: SUTNET Trial: Biological and Clinical Phase II study of Sunitinib in patients with unresectable and/or metastatic pheochromocytoma/paraganglioma | |||||||||||||
Medical condition: Patients with unresectable and/or metastatic pheochromocytomas/paragangliomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002336-15 | Sponsor Protocol Number: 578 | Start Date*: 2011-08-31 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: The effect of prednisolone versus hydrocortisone as glucocorticoid replacement therapy on hypoglycaemia frequency in people with Type 1 diabetes and adrenal insufficiency: a pilot study. | ||||||||||||||||||
Medical condition: Type 1 diabetes and adrenal insufficiency. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004530-38 | Sponsor Protocol Number: ASSTBS-FARONCO-PESETA-20 | Start Date*: 2022-05-30 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOTANE IN PATIENTS WITH ADVANCED ADRENALCORTICAL (PESETA TRIAL) | |||||||||||||
Medical condition: advanced/ metastatic patients with ACC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000494-91 | Sponsor Protocol Number: PEMBR-01 | Start Date*: 2022-12-22 | |||||||||||
Sponsor Name:Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Państwowy Instytut Badawczy | |||||||||||||
Full Title: A multicentre, open-label phase 2 study to evaluate the efficacy and safety of pembrolizumab in the treatment of advanced, progressive adrenocortical carcinoma. | |||||||||||||
Medical condition: carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018074-56 | Sponsor Protocol Number: G0900001:RoSAv1.1:12_09 | Start Date*: 2010-05-05 | |||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Revival of autochthonous adrenocortical stem cells in autoimmune Addison’s disease (RoSA) | |||||||||||||
Medical condition: Autoimmune Addison's disease | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003062-18 | Sponsor Protocol Number: 4071 | Start Date*: 2008-06-05 | |||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust | |||||||||||||
Full Title: Immunotherapeutic Rescue of steroidogenic function in autoimmune Addison’s Disease (RAD): Pilot study | |||||||||||||
Medical condition: Autoimmune Addison's disease (adrenocortical failure) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000115-10 | Sponsor Protocol Number: SPON CU 086 | Start Date*: 2005-10-14 |
Sponsor Name:Cardiff University | ||
Full Title: A randomised, double blind, placebo-controlled, cross-over study of the effects of dehydroepiandrosterone replacement on vascular function in patients with primary and secondary adrenal insufficiency. | ||
Medical condition: Primary and secondary adrenal failure | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006487-24 | Sponsor Protocol Number: ADNorGC | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Helse Bergen HF | |||||||||||||
Full Title: A registry-based, open-label, randomized study to investigate quality-of-life with Plenadren compared with Cortison in participants aged 16-80 with newly diagnosed primary adrenal insufficiency | |||||||||||||
Medical condition: Primary adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000161-40 | Sponsor Protocol Number: AdrenalClock | Start Date*: 2022-07-18 |
Sponsor Name:Medical University of Vienna, Division of Endocrinology | ||
Full Title: Investigating cardiometabolic risk factors and changes in chronobiology patterns in patients with autonomous adrenal cortisol secretion | ||
Medical condition: Autonomous cortisol secretion in patients with adrenal adenoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011531-13 | Sponsor Protocol Number: ICSR | Start Date*: 2009-08-04 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: Relative adrenal insufficiency in cirrhosis: relevance in patients with ascites and treatment with hydrocortisone in refractory ascites | |||||||||||||
Medical condition: cirrhosis and ascites | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001502-28 | Sponsor Protocol Number: PRED-AID | Start Date*: 2019-02-11 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study) | |||||||||||||
Medical condition: Adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000676-33 | Sponsor Protocol Number: 292004 | Start Date*: 2006-09-14 |
Sponsor Name:NV Organon | ||
Full Title: A randomized, open-label, comparative, multi-center trial to evaluate the effects on hemostasis, lipids and carbohydrate metabolism, and on adrenal and thyroid function of a monophasic COC containi... | ||
Medical condition: Hormonal oral contraception in healthy women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.